FFCP PHASE1:Mm9::chr14:29722238..29722242,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=95|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr14:29722238..29722242,-|id=chr14:29722238..29722242,-|ontology_enrichment_celltype=CL:0002679!1.14e-07!1|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000162!9.97e-10!3;UBERON:0001353!9.97e-10!3;UBERON:0000163!9.97e-10!3;UBERON:0006866!9.97e-10!3;UBERON:0001046!9.97e-10!3;UBERON:0000164!9.97e-10!3;UBERON:0000931!9.97e-10!3;UBERON:0001255!4.65e-08!1;UBERON:0001556!4.65e-08!1;UBERON:0000993!7.32e-08!1;UBERON:0002367!9.86e-08!1;UBERON:0009846!9.86e-08!1;UBERON:0003353!9.86e-08!1;UBERON:0004902!9.86e-08!1;UBERON:0003820!9.86e-08!1;UBERON:0009847!9.86e-08!1|ontology_enrichment_uberon_v019_2=UBERON:0001255,3.07e-86,1;UBERON:0001556,3.07e-86,1;UBERON:0000162,5.61e-30,3;UBERON:0001353,5.61e-30,3;UBERON:0000163,5.61e-30,3;UBERON:0006866,5.61e-30,3;UBERON:0001046,5.61e-30,3;UBERON:0000164,5.61e-30,3;UBERON:0000931,5.61e-30,3;UBERON:0000161,1.16e-18,5;UBERON:0004122,1.16e-18,5;UBERON:0003064,1.22e-07,14|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.420883711772948,0.130120442962704,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.213288250535234,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.126473074248515,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.157635144106191,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.141940085208269,0,0,0.329940245945071,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.220528398054962,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.88672132548076,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.50695859978048,0,0,0.0640251524048693,0,0,0,0,0,0,0,0,0,0,0,0.0846146078916765,0,0,0,0,0.118635018124174,0,0,0,0,0,0.233931608445408,0,0,0,0|short_description=p@chr14:29722238..29722242,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=95 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr14:29722238..29722242,- | |||
|description=CAGE_peak_at_chr14:29722238..29722242,- | |||
|id=chr14:29722238..29722242,- | |||
|ontology_enrichment_celltype=CL:0002679!1.14e-07!1 | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000162!9.97e-10!3;UBERON:0001353!9.97e-10!3;UBERON:0000163!9.97e-10!3;UBERON:0006866!9.97e-10!3;UBERON:0001046!9.97e-10!3;UBERON:0000164!9.97e-10!3;UBERON:0000931!9.97e-10!3;UBERON:0001255!4.65e-08!1;UBERON:0001556!4.65e-08!1;UBERON:0000993!7.32e-08!1;UBERON:0002367!9.86e-08!1;UBERON:0009846!9.86e-08!1;UBERON:0003353!9.86e-08!1;UBERON:0004902!9.86e-08!1;UBERON:0003820!9.86e-08!1;UBERON:0009847!9.86e-08!1 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001255,3.07e-86,1;UBERON:0001556,3.07e-86,1;UBERON:0000162,5.61e-30,3;UBERON:0001353,5.61e-30,3;UBERON:0000163,5.61e-30,3;UBERON:0006866,5.61e-30,3;UBERON:0001046,5.61e-30,3;UBERON:0000164,5.61e-30,3;UBERON:0000931,5.61e-30,3;UBERON:0000161,1.16e-18,5;UBERON:0004122,1.16e-18,5;UBERON:0003064,1.22e-07,14 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.420883711772948,0.130120442962704,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.213288250535234,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.126473074248515,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.157635144106191,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.141940085208269,0,0,0.329940245945071,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.220528398054962,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,8.88672132548076,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.50695859978048,0,0,0.0640251524048693,0,0,0,0,0,0,0,0,0,0,0,0.0846146078916765,0,0,0,0,0.118635018124174,0,0,0,0,0,0.233931608445408,0,0,0,0 | |||
|short_description=p@chr14:29722238..29722242,- | |||
}} |
Latest revision as of 04:58, 4 August 2015
Short description: | p@chr14:29722238..29722242, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr14:29722238..29722242, - |
Coexpression cluster: | MCL_coexpression_mm9:95 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
urinary bladder | 3.07e-86 | 1 |
lower urinary tract | 3.07e-86 | 1 |
cloaca | 5.61e-30 | 3 |
anal region | 5.61e-30 | 3 |
embryonic cloaca | 5.61e-30 | 3 |
terminal part of digestive tract | 5.61e-30 | 3 |
hindgut | 5.61e-30 | 3 |
primitive urogenital sinus | 5.61e-30 | 3 |
proctodeum | 5.61e-30 | 3 |
orifice | 1.16e-18 | 5 |
genitourinary system | 1.16e-18 | 5 |
intermediate mesoderm | 1.22e-07 | 14 |